Nuplura PH differs from other M. haemolytica vaccines because of the advanced cellular technology used to purify antigens in the vaccine. As the only U.S. cattle vaccine developed with recombinant technology, Nuplura PH contains only purified leukotoxin to deliver the strongest immune response with minimal reactivity. It is the first new M. Tiaemolytica vaccine available in the U.S. in more than 10 years.
Pages to are hidden for
"Novartis Introduces Nuplura(TM) PH Vaccine"Please download to view full document